Drug Shortage Report for XYLOCARD
Report ID | 222692 |
Drug Identification Number | 00001937 |
Brand name | XYLOCARD |
Common or Proper name | lidocaine HCI 100mg 10x5mL SU Glass Ampoule |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 Ampoule |
ATC code | C01BB |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-09-01 |
Actual start date | |
Estimated end date | 2024-09-30 |
Actual end date | 2024-05-09 |
Shortage status | Avoided shortage |
Updated date | 2024-05-09 |
Company comments | VR44677CA1 XYLOCARD 20MG/ML AMP 10X5ML CA ASP |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-05-09 | French | Compare |
v3 | 2024-05-09 | English | Compare |
v2 | 2024-03-18 | French | Compare |
v1 | 2024-03-18 | English | Compare |
Showing 1 to 4 of 4